![Clinical/Pathological/Genetic Features of Arrhythmogenic Cardiomyopathies](/_next/image?url=https%3A%2F%2Fcoatconnect-files.s3.amazonaws.com%2FDev%2FCover-f7811ec8-cec5-45b9-98b3-3917c346865e-2c9057d5-a736-4de5-a36c-081eb364295f-ani-kolleshi-7jjnJ-QA9fY-unsplash_1920X1080.webp%3FAWSAccessKeyId%3DAKIAJTMHAFAXQLGGIHMA%26Expires%3D1804066279%26Signature%3DD1OITRwiAraj1yK%252B8XLe%252FjS2BsQ%253D&w=3840&q=75)
Clinical/Pathological/Genetic Features of Arrhythmogenic Cardiomyopathies
![Opus Medicus, Inc.](/_next/image?url=https%3A%2F%2Fcoatconnect-files.s3.amazonaws.com%2FDev%2FThumb-379803f9-96d5-4388-afc8-abb9f58b43f8-speakers-opus-medicus-inc.jpg%3FAWSAccessKeyId%3DAKIAJTMHAFAXQLGGIHMA%26Expires%3D1830760390%26Signature%3DXlJyUXFPdjqDL%252BGbDreLv7VgQjg%253D&w=3840&q=75)
![Jeffrey E. Safitz](/_next/image?url=https%3A%2F%2Fcoatconnect-files.s3.amazonaws.com%2FDev%2FThumb-85c2df94-8170-4ff7-a935-4ae57a1bc8a4-speakers-jeffrey-e-safitz.jpg%3FAWSAccessKeyId%3DAKIAJTMHAFAXQLGGIHMA%26Expires%3D1830760827%26Signature%3D00aQcFoQqWtZoxaTsG20OUpzGQk%253D&w=3840&q=75)
Clinical/Pathological/Genetic Features of Arrhythmogenic Cardiomyopathies is organized by Opus Medicus, Inc.
Last Review Date: 22-Jan-2022
Expiration Date: 21-Jan-2025
Description:
This course uses a case-based approach to illustrate the key clinical, pathological, and genetic features of arrhythmogenic cardiomyopathies, the most arrhythmogenic form of human heart disease that is often fatal at a young age.
Topics:
• Description of clinical disease and molecular basis.
• Gross Pathology of ARVC.
• Microscopic Pathology of ARVC.
• Genetic mutations associated WITH ARVC.
• Case descriptions of Classical ARVC.
• Case descriptions of severe ARVC with Biventricular Dysfunction
• Naxos disease.
Objectives:
• Understand the major clinical, pathological and genetic features of the arrhythmogenic cardiomyopathies.
• Recognize that biventricular disease is common.
• Recognize that subepicardial (as opposed to subendocardial) injury is a unique feature of arrhythmogenic cardiomyopathies.
Additional details will be posted as soon as information is available.